FDA Approved: DASATINIB — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals' original application to market a generic dasatinib product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)